CVS Health Corporation · NYSE:CVS
CVS Health — Caremark RX — Merger or Acquisition (February 2007)
34 slides from CVS Health's merger presentation, Feb 2, 2007
Slide 1: Cautionary Statement Regarding Forward-Looking Statements
Cautionary Statement Regarding Forward-Looking Statements This document contains certain forward-looking statements about CVS and Caremark. When used in this document, the words "anticipates", "may", "can", "believes", "expects", "projects", "intends", "likely", "will", "to be" and any similar expre
Slide 2: Important Information
Important Information CVS and Caremark have filed a preliminary joint proxy statement/prospectus with the SEC in connection with the proposed merger. CVS and Caremark urge investors and stockholders to read the joint proxy statement/prospectus when it becomes available and any other relevant documen
Slide 3: Caremark Profile
Caremark Profile |X| Leading pharmaceutical services company providing comprehensive drug benefit services to health plan sponsors and their participants |X| Clients - Corporate health plans - Managed care organizations and insurance companies - Unions - Government agencies |X| National Prescription
Slide 4: Caremark Profile
Caremark Profile |X| Caremark retail network includes 60,000 pharmacies nationwide |X| Caremark operations - 7 mail pharmacies - 21 specialty pharmacies - 9 customer call centers - 12 client-site pharmacies - Industry's only FDA regulated repackaging plant |X| 13,000 employees, including 1,300 pharm
Slide 5: Caremark Services Uniquely Integrated
Caremark Services Uniquely Integrated Specialty Pharmacy |X| Largest provider of premier specialty pharmacy programs A Highly Integrated Pharmacy Benefit Management Offering |X| Industry-leading mail expertise |X| Highly-valued generic substitution programs |X| Broad clinical offerings and analytics
Slide 6: CVS Profile
CVS Profile |X| Nation's largest retail pharmacy with more than 6,200 retail and specialty stores in 43 states. |X| Services - CVS/pharmacy stores - CVS.com - MinuteClinic - PharmaCare (PBM, Mail, Specialty services) |X| 170,000 employees, including 20,000 pharmacists |X| 2006 revenue $43.8 billion
Slide 7: CVS/Caremark Merger Overview
CVS/Caremark Merger Overview - -------------------------------------------------------------------------------- Name CVS/Caremark Corporation - -------------------------------------------------------------------------------- Symbol CVS (NYSE) - -------------------------------------------------------
Slide 8: CVS/Caremark Governance Structure Upon Close
CVS/Caremark Governance Structure Upon Close |X| Provides for annual election of all directors |X| Will have majority voting provision |X| Separate CEO and Chairman |X| Has stock ownership guidelines for D&O |X| Allows stockholders to ratify auditors 9
Slide 9: Merger Developed Through Extensive and Thorough Board Management Process
CVS/Caremark Merger Developed Through Extensive and Thorough Board Management Process |X| Management discussed combination thoroughly over 12 months - Mac Crawford and Tom Ryan began discussing a potential strategic combination in October 2005 - The CEOs discussed the potential deal numerous times b
Slide 10: Caremark Board Considered Consumer Strategy Superior to PBM Combination
Caremark Board Considered Consumer Strategy Superior to PBM Combination (Aug 2006) 11
Slide 11: CVS/Caremark Merger Capitalizes on Evolving Industry Trends
CVS/Caremark Merger Capitalizes on Evolving Industry Trends - -------------------------------------------------------------------------------- Market Trends CVS/Caremark Merger Benefit - -------------------------------------------------------------------------------- Growing Consumerism Gives consum
Slide 12: CVS/Caremark Merger is in Best Interest of Shareholders
CVS/Caremark Merger is in Best Interest of Shareholders |X| Financial benefits immediate and concrete |X| High certainty of completion |X| Significant strategic benefits |X| Business opportunity |X| Solid financial position |X| Proven management teams 13
Slide 13: CVS/Caremark Merger Enhances Shareholder Value
CVS/Caremark Merger Enhances Shareholder Value Financial Benefits |x| 1.67 shares CVS/Caremark stock for each share of CMX |X| $2.00 special dividend to CMX shareholders of record |X| Accretive repurchase of 150 million CVS/Caremark shares |X| $500 M in cost synergies, integration planning underway
Slide 14: CVS/Caremark Merger Enhances Shareholder Value: Business Opportunity
CVS/Caremark Merger Enhances Shareholder Value Business Opportunity |X| Clients overwhelmingly positive |X| Differentiated services will be compelling to payors |X| Unmatched in-store services will increase consumer loyalty |X| February close creates opportunity for 2007 selling season Financial Fle
Slide 15: Back up for Cost Synergy Calculations
Back up for Cost Synergy Calculations |X| Cost Synergies - Conservatively estimated - Calculated by outside consultant retained by legal counsel - Rigorous analysis based on input from both management teams - Based on details from customer and client contracts |X| Initial estimate of $400 M - Bulk o
Slide 16: Near-Term Revenue Opportunities Unique to CVS/Caremark Combination
Near-Term Revenue Opportunities Unique to CVS/Caremark Combination |X| Incremental opportunities of $800 M to $1 B in 2008 - Half from PBM, half from retail |X| Revenue estimates based on market research and PharmaCare-CVS experience |X| Revenue synergy examples: - Improved access/services for PBM s
Slide 17: Integration Planning Underway
Integration Planning Underway |X| Teams already engaged in integration planning |X| Scope defined and focused on three areas - PBM integration - Corporate integration - New go-to market products and services |X| Individuals for steering committees, project management and core teams have been establi
Slide 18: Caremark Board of Directors Thoroughly Considered Express Proposal
Caremark Board of Directors Thoroughly Considered Express Proposal |X| Caremark BOD met six times to consider Express proposal - 1 2/18/06, 12/22/06, 12/27/06, 1/3/07, 1/5/07 and 1/24/07 |X| Legal counsel thoroughly reviewed legal aspects numerous times - Fiduciary duties and standards under Delawar
Slide 19: Board Concluded Express Proposal Not in Best Interests of Shareholders
Caremark Board of Directors Concluded that Express Proposal Not in Best Interests of Shareholders |X| Caremark BOD met six times to consider Express proposal - 12/18/06, 12/22/06, 12/27/06, 1/3/07, 1/5/07 and 1/24/07 |X| Legal counsel thoroughly reviewed legal aspects numerous times - Fiduciary duti
Slide 20: Express Scripts Offer Includes Material Conditions
Express Scripts Offer Includes Material Conditions |X| A due diligence review |X| Satisfaction of financing conditions |X| Anti-trust and other regulatory approvals |X| Approval by their own shareholders - a process they have not even begun and, which by their own admission, would prevent their illu
Slide 21: Value of CVS/Caremark Transaction for Caremark Shareholders
Value of CVS/Caremark Transaction for Caremark Shareholders 22
Slide 22: Dispelling Myths
Dispelling Myths MYTH REALITY - ------------------------------------------------------------------------------------------------------------------------------------ Incentive Alignment CVS "makes money when patients and |X| Well understood that retail and PBM incentives are aligned clients spend mon
Slide 23: CVS/Caremark Merger is in the Best Interests of Shareholders
CVS/Caremark Merger is in the Best Interests of Shareholders CVS/Caremark Merger .. Immediate and concrete financial benefits . February 2007 close . Significant strategic benefits . Clients supportive . Proven management teams ESRX Proposal . Highly conditional offer . Financial benefits suspect .
Slide 24: CVS/Caremark Merger is in Best Interest of Shareholders
CVS/Caremark Merger is in Best Interest of Shareholders |X| Financial benefits immediate and concrete |X| High certainty of completion |X| Significant strategic benefits |X| Business opportunity |X| Solid financial position |X| Proven management teams 25
Slide 25: CVS/Caremark Merger Enhances Shareholder Value
» Financial benefits immediate and concrete » High certainty of completion » Significant strategic benefits » Business opportunity » Solid financial position » Proven management teams CVS/Caremark Merger Enhances Shareholder Value CVS/pharmacy CAREMABK -s Expect somethingextaa
Slide 26: Strong Board Oversight
Strong Board Oversight |X| Caremark's Board members have complied with their fiduciary duties and obligations under Delaware law in considering both the CVS transaction and the Express Scripts proposal. |X| Mac Crawford, as Chairman of the Board, serves at the direction of Caremark's Board of Direct
Slide 27: Caremark Board of Directors
Caremark Board of Directors C. David Brown II, 54, has been a member of the Board of Directors since March 2001. He was the Managing Partner of the Orlando, Florida office of Broad and Cassel, a law firm, from 1989 until March 2000, when he became Chairman of the firm. Harris Diamond, 53, has been a
Slide 28: Caremark Board of Directors
Caremark Board of Directors Michael D. Ware, 60, has been a member of the Board of Directors since March 2004. Prior to joining the Company's Board, Mr. Ware served as a director of AdvancePCS beginning in July 1993, and he was also a member of the Compensation and Audit Committees of AdvancePCS. Mr
Slide 29: Caremark Board of Directors
Caremark Board of Directors Roger L. Headrick, 69, has been a member of the Board of Directors since September 1996 and was named lead director in February 2004. He is Managing General Partner of HMCH Ventures, a private venture capital investment partnership. Since June 1989, Mr. Headrick has been
Slide 30: Caremark Board of Directors
Caremark Board of Directors Edwin M. Crawford, 57, was named Chairman of the Board of Directors in December 1998. He has served as Chief Executive Officer and as a director of the Company since March 1998. He also served as President of the Company from March 1998 until May 2000, and, effective Marc
Slide 31: CVS Board of Directors
CVS Board of Directors David W. Dorman Director since 2006 (Age 53) Mr. Dorman is the retired Chairman of the Board and Chief Executive Officer of AT&T Corporation ("AT&T Corp."). From November 2005 until his retirement in January 2006, Mr. Dorman served as President and a director of AT&T, Inc. (fo
Slide 32: CVS Board of Directors
CVS Board of Directors William H. Joyce Director since 1994 (Age 71) Dr. Joyce has been Chairman of the Board and Chief Executive Officer of Nalco Company, a leading provider of integrated water treatment and process improvement services, chemicals and equipment programs for industrial and instituti
Slide 33: CVS Board of Directors
CVS Board of Directors Thomas M. Ryan Director since 1996 (Age 54) Mr. Ryan has been President and Chief Executive Officer of CVS Corporation since May 1998 and Chairman of CVS Corporation since April 1999; he has also been President and Chief Executive Officer of CVS Pharmacy, Inc. since 1994. Mr.
Slide 34: Cautionary Statement Regarding Forward-Looking Statements
Cautionary Statement Regarding Forward-Looking Statements This document contains certain forward-looking statements about CVS and Caremark. When used in this document, the words “anticipates”, “may”, “can”, “believes”, “expects”, “projects”, “intends”, “likely”, “will”, “to be” and any similar expre